Evidence map›Paper›PMID 14720390›Full record

ArticleEmerging infectious diseases2003

Global distribution of rubella virus genotypes.

Du-Ping Zheng, Teryl K Frey, Joseph Icenogle, Shigetaka Katow, Emily S Abernathy, Ki-Joon Song, Wen-Bo Xu, Vitaly Yarulin, R G Desjatskova, Yair Aboudy and 2 more

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Rubella epidemic strain, Greece, 1999.Emerging infectious diseases · 2004
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Du-Ping ZhengGeorgia State University, Atlanta, Georgia 30303, USA.
Teryl K Frey
Joseph Icenogle
Shigetaka Katow
Emily S Abernathy
Ki-Joon Song
Wen-Bo Xu
Vitaly Yarulin
R G Desjatskova
Yair Aboudy
Gisela Enders
Margaret Croxson

Funding

MOLECULAR BIOLOGY OF RUBELLA VIRUSR01AI021389 · NIAID · GEORGIA STATE UNIVERSITY · PI FREY, TERYL K · 1987 to 2006
$1.7M
MOLECULAR BIOLOGY OF RUBELLA VIRUSR23AI021389 · NIAID · GEORGIA STATE UNIVERSITY · PI FREY, TERYL K · 1985 to 1986
–
NIAID NIH HHS AI21389NIAID NIH HHS R01 AI021389
6 · The paper itself

Abstract

Phylogenetic analysis of a collection of 103 E1 gene sequences from rubella viruses isolated from 17 countries from 1961 to 2000 confirmed the existence of at least two genotypes. Rubella genotype I (RGI) isolates, predominant in Europe, Japan, and the Western Hemisphere, segregated into discrete subgenotypes; international subgenotypes present in the 1960s and 1970s were replaced by geographically restricted subgenotypes after approximately 1980. Recently, active subgenotypes include one in the United States and Latin America, one in China, and a third that apparently originated in Asia and spread to Europe and North America, starting in 1997, indicating the recent emergence of an international subgenotype. A virus that potentially arose as a recombinant between two RGI subgenotypes was discovered. Rubella genotype II (RGII) showed greater genetic diversity than did RGI and may actually consist of multiple genotypes. RGII viruses were limited to Asia and Europe; RGI viruses were also present in most of the countries where RGII viruses were isolated.

Indexed as

Base SequenceCluster AnalysisDNA, ViralGenetic VariationGenotypeHumansMolecular Sequence DataPhylogenyRubellaRubella virusSequence Analysis, DNAViral Envelope ProteinsDNA, ViralViral Envelope Proteins

Identifiers

PMID14720390
PMCPMC3034328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.